Next generation sequencing (NGS) is quickly gaining regulatory agencies’ acceptance as a sensitive and un-biased detection method for adventitious agents. Avance Biosciences is positioned to be a strategic partner with our pharmaceutical clients in establishing this powerful tool for testing viral contaminants in cell substrates and biological products.
- Testing adventitious viruses in biological products
- Raw materials
- Final products
- Matrix with viral spike-in
- Testing adventitious viruses in cell substrates
- Cell culture